Silexion Therapeutics Corp (NASDAQ:SLXN) price closed lower on Tuesday, February 04, and dropping -20.38% below its previous close.
A look at the daily price movement shows that the last close reads $1.57, with intraday deals fluctuated between $1.2 and $1.6199. The company’s 5Y monthly beta was ticking -0.111. Taking into account the 52-week price action we note that the stock hit a 52-week high of $122.02 and 52-week low of $0.57. The stock subtracted -37.19% on its value in the past month.
Silexion Therapeutics Corp, which has a market valuation of $4.99 million, is expected to release its quarterly earnings report in March.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.
The overview shows that SLXN’s price is at present -16.43% off the SMA20 and -43.65% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 44.60, with weekly volatility standing at 36.68%. The indicator jumps to 22.69% when calculated based on the past 30 days. Silexion Therapeutics Corp (NASDAQ:SLXN)’s beta value is holding at 0.04, while the average true range (ATR) indicator is currently reading 0.51.
An analysis of the Silexion Therapeutics Corp (NASDAQ:SLXN) stock in terms of its daily trading volume indicates that the 3-month average is 11.03 million. However, this figure increases on the past 10-day timeline to an average of 60.24 million.
Current records show that the company has 4.00M in outstanding shares. The insiders’ percentage holdings are 47.50% of outstanding shares while the percentage share held by institutions stands at 11.73%. The stats also highlight that short interest as of 2024-11-15, stood at 35842.0 shares, which puts the short ratio at the time at 0.23. From this we can glean that short interest is 308.00 of company’s current outstanding shares. Notably, we see that shares short in November rose slightly given the previous month’s figure stood at 9885.0. But the -37.81% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
